In addition to tumor-suppressing proteins that were enriched in CW-MSC CM such as CALR, we identified PCOLCE as a novel tumor-suppressing protein and proposed a regulatory axis of PCOLCE-APP for the treatment of OS. Here, APP is linked to neoplasm.